Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SRTS Sensus Healthcare Inc
- Stocks
- Healthcare
- NASDAQ: SRTS
Price (delayed)
$4.73
Market cap
$77.79M
P/E Ratio
43
Dividend/share
N/A
EPS
$0.11
Enterprise value
$59.37M
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology
Highlights
The revenue has grown by 25% YoY but it has contracted by 6% from the previous quarter
The gross profit has increased by 16% year-on-year but it has declined by 9% since the previous quarter
The price to earnings (P/E) is 107% higher than the last 4 quarters average of 20.8
The net income has dropped by 73% since the previous quarter and by 61% year-on-year
Key stats
What are the main financial stats of SRTS
Market
Valuations
Earnings
Shares outstanding
16.45M
Market cap
$77.79M
Enterprise value
$59.37M
Price to earnings (P/E)
43
Price to book (P/B)
1.47
Price to sales (P/S)
1.96
EV/EBIT
17.16
EV/EBITDA
15.15
EV/Sales
1.5
Revenue
$39.49M
Gross profit
$22.12M
Operating income
$2.56M
Net income
$1.8M
EBIT
$3.46M
EBITDA
$3.92M
Free cash flow
$4.63M
Per share
Balance sheet
Liquidity
EPS
$0.11
EPS diluted
$0.11
Free cash flow per share
$0.28
Book value per share
$3.22
Revenue per share
$2.42
TBVPS
$3.68
Total assets
$60.21M
Total liabilities
$7.18M
Debt
$654,000
Equity
$53.03M
Working capital
$47.47M
Debt to equity
0.01
Current ratio
8.06
Quick ratio
5.52
Net debt/EBITDA
-4.7
Margins
Efficiency
Dividend
EBITDA margin
9.9%
Gross margin
56%
Net margin
4.6%
Operating margin
6.5%
Return on assets
3%
Return on equity
3.3%
Return on invested capital
10%
Return on capital employed
6.5%
Return on sales
8.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SRTS stock price
How has the Sensus Healthcare stock price performed over time
Intraday
-0.21%
1 week
-1.66%
1 month
-1.46%
1 year
-8.86%
YTD
-31.65%
QTD
0%
Financial performance
How have Sensus Healthcare's revenue and profit performed over time
Revenue
$39.49M
Gross profit
$22.12M
Operating income
$2.56M
Net income
$1.8M
Gross margin
56%
Net margin
4.6%
The net income has dropped by 73% since the previous quarter and by 61% year-on-year
SRTS's net margin has dropped by 71% since the previous quarter and by 69% year-on-year
SRTS's operating income has shrunk by 68% QoQ and by 53% YoY
Sensus Healthcare's operating margin has plunged by 66% from the previous quarter and by 62% YoY
Price vs fundamentals
How does SRTS's price correlate with its fundamentals
Growth
What is Sensus Healthcare's growth rate over time
Valuation
What is Sensus Healthcare stock price valuation
P/E
43
P/B
1.47
P/S
1.96
EV/EBIT
17.16
EV/EBITDA
15.15
EV/Sales
1.5
The price to earnings (P/E) is 107% higher than the last 4 quarters average of 20.8
Sensus Healthcare's EPS has shrunk by 73% QoQ and by 62% YoY
SRTS's P/B is 39% below its 5-year quarterly average of 2.4 and 14% below its last 4 quarters average of 1.7
SRTS's equity is down by 5% since the previous quarter but it is up by 3.6% year-on-year
The P/S is 39% lower than the 5-year quarterly average of 3.2 and 15% lower than the last 4 quarters average of 2.3
The revenue has grown by 25% YoY but it has contracted by 6% from the previous quarter
Efficiency
How efficient is Sensus Healthcare business performance
Sensus Healthcare's ROE has plunged by 73% from the previous quarter and by 66% YoY
Sensus Healthcare's ROA has plunged by 73% from the previous quarter and by 66% YoY
The company's return on invested capital has shrunk by 61% QoQ and by 54% YoY
Sensus Healthcare's return on sales has shrunk by 59% QoQ and by 57% YoY
Dividends
What is SRTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SRTS.
Financial health
How did Sensus Healthcare financials performed over time
SRTS's quick ratio is down by 22% since the previous quarter and by 12% year-on-year
Sensus Healthcare's total liabilities has increased by 18% YoY and by 13% from the previous quarter
SRTS's debt is 99% smaller than its equity
SRTS's debt is down by 12% year-on-year but it is up by 9% since the previous quarter
SRTS's equity is down by 5% since the previous quarter but it is up by 3.6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.